Hypertension, Vol 7, 593-596, Copyright © 1985 by American Heart Association
MJ Sole, CR Benedict, MG Myers, FH Leenen and GH Anderson
The blood pressure and plasma norepinephrine response to oral tyrosine, the
precursor of norepinephrine, supplementation (2.5 g t.i.d.) of regular
meals was examined in 13 untreated patients with mild essential
hypertension. Using a randomized double-blind crossover design, each 2-
week treatment was followed by a 2-week supplement-free interval. Supine
and standing blood pressure and plasma norepinephrine levels were measured
at the beginning and end of each 2-week treatment. Plasma tyrosine levels
increased (p less than 0.001) from 71.2 +/- 8.0 nM/ml at baseline to 152.8
+/- 17.4 nM/ml 2 hours after the tyrosine supplement. Blood pressure under
control conditions was 144 +/- 3 Hg systolic, 91 +/- 2 mm Hg diastolic (109
+/- 2 mm Hg mean) after 30 minutes in the supine position and 148 +/- 4 mm
Hg systolic, 102 +/- 3 mm Hg diastolic (117 +/- 3 mm Hg mean) after 5
minutes of standing. Plasma norepinephrine levels were 191 +/- 18 pg/ml in
the supine subjects and 390 +/- 33 pg/ml in the standing subjects. No
difference in systolic, diastolic, or mean blood pressure, heart rate, or
plasma norepinephrine levels were seen between the beginning and end of
each period or between groups. Individual changes in blood pressure showed
no correlation with individual changes in norepinephrine levels. These
results indicate that the addition of a tyrosine supplement to the usual
diet of mild hypertensive subjects has no beneficial effect on blood
pressure.
ARTICLES
Chronic dietary tyrosine supplements do not affect mild essential hypertension
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |